MONOOX 1.5 mg/0.5 ml, eye drop solution in a single-dose container 20 single-dose containers of 0.5 ml
Active ingredients: OFLOXACINE
Commercialized according to BDPMDispensing in France: Prescription only
Eye drop solution20 single-dose containers of 0.5 mlophtalmique
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- MONOOX 1,5 mg/0,5 ml, collyre en solution en récipient unidose
- Pharmaceutical form
- collyre en solution
- Route of administration
- ophtalmique
- Presentation description
- 20 récipient(s) unidose(s) polyéthylène basse densité (PEBD) de 0,5 ml
- Marketing authorisation holder
- HORUS PHARMA
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 24 Jan 2013
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69918249CIP72661912CIP133400926619121Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| OFLOXACINEcollyre | 1,5 mg · un récipient unidose de 0,5 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.